"Tackling TB and drug-resistant TB must be at the heart of any global action against antimicrobial resistance."
The TB Europe Coalition released a policy paper, Tuberculosis: The cornerstone of the AMR threat, providing a brief overview of what antimicrobial resistance (AMR) is. Furthermore, the paper looks in more detail at drug-resistant TB, and discusses why countries need to invest more in research and development of new drugs to tackle it.
To access the policy paper, click here.
Source: TB Europe Coalition